END-TO-END CELL THERAPY AUTOMATION

The present disclosure provides an automated method of producing genetically modified immune cells, including chimeric antigen receptor T (CAR T) cells, utilizing a fully-enclosed cell engineering system. La présente invention concerne un procédé automatisé de production de cellules immunitaires gén...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	O'CONNOR, JOSEPH, SMITH, TIMOTHY, SIEHOFF, ANN, SHI, YALING, MCAFEE, ERIKA, ABRAHAM, EYTAN, BANDAPALLE, SAMATHA, GLEISSNER, TIMO, PURPURA, KELLY, TRAINOR, NUALA
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR COMPOSITIONS THEREOF CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES CULTURE MEDIA ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure provides an automated method of producing genetically modified immune cells, including chimeric antigen receptor T (CAR T) cells, utilizing a fully-enclosed cell engineering system. La présente invention concerne un procédé automatisé de production de cellules immunitaires génétiquement modifiées, comprenant des cellules T de récepteur d'antigène chimérique (CAR T), à l'aide d'un système d'ingénierie cellulaire entièrement clos.